The 2021 Molecular genetics EQA scheme registration deadline is in:
0
days
0
hours
0
mins
0
secs
hero-bg

2021 EQA schemes open for registration

We are delivering 76 different EQA schemes covering 8 different core areas of genomics:

- Molecular genetics
- Molecular pathology (including FFPE and plasma based testing)
- Pharmacogenetics
- Technology (e.g NGS)
- Prenatal and Postnatal testing
- Virology
- Interlaboratory Comparisons (sample exchanges).

To browse our catalogue, or download a copy of the participant guide, please follow the link below.

We are a not-for-profit organisation promoting quality in genetic testing by establishing, harmonising and disseminating best practice.

We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.

    Membership

    Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.

    EMQN Membership

    Best Practice

    We facilitate the development and publication of best practice guidelines. To participate in a best practice meeting you must be a registered member of the network.

    Best Practice with EMQN

    The latest news and press releases

    Posted 3 days ago

    Diaceutics launches world’s first Diagnostic Network for Precision Medicine

    28.10.2020  Diaceutics PLC, (AIM: DXRX), today announced the launch of DXRX – The Diagnostic Network® which has been designed to…
    Posted 1 month ago

    Press release: EMQN partners with Diaceutics Plc to provide its oncogene panel EQA scheme via the DXRX platform

    Released: 28th September 2020. EMQN CIC is collaborating with Diaceutics on a pilot study involving mutations in the EGFR, PIK3CA,…
    Translate »